Home/Pipeline/Intranasal RSV Vaccine

Intranasal RSV Vaccine

Respiratory Syncytial Virus Infection

PreclinicalActive

Key Facts

Indication

Respiratory Syncytial Virus Infection

Phase

Preclinical

Status

Active

Company

BioComo

About BioComo

Japanese biotech developing intranasal spray vaccines using a proprietary human parainfluenza virus vector platform for respiratory infections and cancer.

View full company profile

Therapeutic Areas

Infectious Disease Oncology

Other Respiratory Syncytial Virus Infection Drugs

Drug	Company	Phase	Status
RSV Vaccine	VLP Biotech	Pre-clinical	Active
VELO RSV Test	LEX Diagnostics	Development	Active
RSV mAb	Trellis Bioscience	Preclinical	Active